Skip to content

Risk Factors for Postoperative Fever and Sepsis Following Retrograde Intrarenal Surgery

Prospective Evaluation of Clinical, Laboratory and Operative Predictors of Postoperative Fever and Sepsis After Retrograde Intrarenal Surgery (RIRS)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07295925
Acronym
SARIS
Enrollment
250
Registered
2025-12-22
Start date
2026-01-31
Completion date
2026-12-31
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Keywords

RIRS, Sepsis, Urolithiasis, Endourology, Retrograde Intrarenal Surgery, Postoperative Fever, Postoperative Sepsis, Ureteroscopy

Brief summary

This prospective clinical study aims to evaluate preoperative, intraoperative, and postoperative characteristics of patients undergoing retrograde intrarenal surgery (RIRS) for urinary stone disease. A total of approximately 250 patients will be assessed to identify clinical, laboratory, and operative factors associated with postoperative fever and sepsis. By systematically collecting and analyzing perioperative data, the study seeks to determine independent predictors that may support improved risk stratification and patient safety in endourological practice.

Detailed description

Urinary stone disease is a common global health problem with an increasing incidence and significant clinical and economic burden. Retrograde intrarenal surgery (RIRS) has become a widely accepted, minimally invasive, and effective treatment option for renal and proximal ureteral stones. Advances in flexible ureteroscope design, laser technologies, and endourological instrumentation have further improved the safety, efficiency, and applicability of RIRS. As a result, there has been a marked increase in the preference for RIRS among urologists in recent years. Despite its advantages, RIRS is associated with complication rates reported between 9% and 25%. Postoperative fever and urinary tract infection are the most frequently observed complications and may progress to sepsis, which represents a potentially life-threatening condition in patients with urinary stone disease. These infectious events remain a concern even when appropriate antibiotic prophylaxis and aseptic surgical principles are applied. Identifying risk factors that may predict postoperative infection and sepsis is therefore essential for improving perioperative decision-making and patient safety. Previous studies have suggested potential associations between operative characteristics, preoperative bacteriuria, patient-related comorbidities, and postoperative infectious outcomes; however, most available evidence originates from retrospective analyses with limited variables. There remains a need for prospective, systematically collected data evaluating a broad set of perioperative clinical and laboratory parameters to better define predictive factors. This prospective patient registry study aims to evaluate comprehensive perioperative variables to identify predictors of postoperative urinary tract infection and sepsis following RIRS. Parameters to be assessed include operative time, stone burden, intraoperative irrigation characteristics, perioperative cultures, and a detailed panel of inflammatory biomarkers such as C-reactive protein, procalcitonin, albumin, fibrinogen, and D-dimer. The study will also record the onset, duration, and severity of postoperative fever, together with other clinical findings relevant to infectious complications. Through this structured approach, the study seeks to determine independent risk factors that may assist clinicians in predicting, preventing, and managing postoperative infection and sepsis in patients undergoing RIRS.

Interventions

None listed

Sponsors

TC Erciyes University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older. * Patients scheduled to undergo retrograde intrarenal surgery (RIRS) for the treatment of renal or ureteral stones. * Completion of routine preoperative and postoperative clinical assessments required for RIRS. * Ability to provide informed consent.

Exclusion criteria

* Terminal-stage malignancy. * Bleeding diathesis or known immunodeficiency. * Active infectious condition at the time of surgery. * Patients deemed unsuitable for anesthesia or surgery by the Department of Anesthesiology. * Pregnancy. * Contraindications to RIRS or inability to complete required perioperative evaluations.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Postoperative SepsisWithin 72 hours after surgeryPostoperative sepsis will be defined according to Sepsis-3 criteria, based on suspected or confirmed infection and an increase of ≥ 2 points in the Sequential Organ Failure Assessment (SOFA) score within 72 hours after retrograde intrarenal surgery (RIRS).

Secondary

MeasureTime frameDescription
Number of Participants With Systemic Inflammatory Response Syndrome (SIRS)First 24 hours after surgerySIRS will be defined according to standard clinical criteria, including abnormalities in body temperature, heart rate, respiratory rate and leukocyte count after retrograde intrarenal surgery (RIRS).
Number of Participants With Positive Postoperative Urine CultureWithin 72 hoursGrowth of ≥10⁵ CFU/mL of a single organism in a postoperative urine culture.
Number of Participants With Postoperative FeverWithin 72 hours after surgeryPostoperative fever will be defined as a body temperature ≥38ºC recorded at least twice within 72 hours after retrograde intrarenal surgery (RIRS).
Number of Participants With Positive Stone CultureUp to 72 hours after surgeryPresence of bacterial growth in stone culture obtained during retrograde intrarenal surgery (RIRS), defined as any clinically significant pathogen isolated from stone fragments
Length of Hospital Stay (days)From the date of surgery until hospital discharge, assessed up to 30 days postoperatively.Length of hospital stay will be defined as the number of days from the date of surgery to the date of hospital discharge
Number of Participants with Positive Postoperative Blood CultureWithin 72 hoursDetection of pathogenic microorganisms from blood samples obtained in the postoperative period.

Countries

Turkey (Türkiye)

Contacts

Primary ContactMehmet F. Kesici, M.D.
mehmetfurkankesici@erciyes.edu.tr+90554 661 30 33
Backup ContactEmre C. Akınsal, Assoc. Prof.
ecakinsal@erciyes.edu.tr+90 352 207 66 66

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026